In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses-Reference-Cited by-同舟云学术

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses

Published:2020-07-01 Issue:4 Volume:35 Page:782-787
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kang Chang Kyung,Seong Moon-Woo,Choi Su-Jin,Kim Taek Soo,Choe Pyoeng Gyun,Song Sang Hoon,Kim Nam-Joong,Park Wan Beom,Oh Myoung-don

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2020-157.pdf

Reference22 articles.

1. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

2. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings

3. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

4. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis;The American Journal of Emergency Medicine;2024-11

2. Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19;Microorganisms;2024-08-16

3. An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review;International Journal of Biological Macromolecules;2024-05

4. Hydroxychloroquine: Pharmacokinetics and Toxicity;Journal of Clinical Pharmacy and Therapeutics;2024-01-24

5. Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection;Future Virology;2023-10